The International Alliance of Saiaojin Cancer Hospital, located in Los Angeles, USA, is a unicorn-type biotech enterprise specializing in molecular biology, cell research, and clinical diagnosis and treatment applications. It has established long-term strategic research partnerships with world-leading research institutions such as Harvard University, Yale University, Massachusetts Institute of Technology, University of Southern California, and Stanford University. Leveraging internationally leading core cell biotechnology, the group has obtained multiple world-class patents and won the "McEwen Innovation Award" (Nobel-level), the highest award of the World Stem Cell Society. Among them, the technology of inducing massive proliferation of neutrophils and macrophages from hematopoietic progenitor cells in vitro is recognized by the industry as a world-class breakthrough new technology.